MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program is a paper indexed in ScholarIQ from OpenAlex.
How many citations does MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program have?
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program has 233 citations in the OpenAlex counts ScholarIQ stores.
When was MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program published?
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program has 2021 year in the ScholarIQ index.
What is the open-access status of MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program?
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program has gold oa status in the ScholarIQ index.
What is the DOI of MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program?
The DOI for MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program is on the source record.
What is the PMID of MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program?
The PMID for MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program is on the source record.
What is the OpenAlex record for MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program?
The OpenAlex for MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program is on the source record.